More from Dividend.com
Referenced Stocks

Merck Upgraded to “Outperform” at BMO (MRK)

By Dividend.com,  November 12, 2012, 09:20:28 AM EDT

On Monday analysts at BMO Financial upgraded pharmaceutical company Merck & Co., Inc. ( MRK ) after positive data from two early stage products.

The analysts boosted its rating on Merck from "Market Perform" to "Outperform" with a price target of $50. The target is a +13.5% increase from Friday's closing price o $44.05.

Merck shares were up 47 cents, or +1.07%, in premarket trading on Monday.

The Bottom Line
Shares of Merck ( MRK ) have a 3.81% dividend yield, based on Friday's closing stock price of $44.05. The stock has technical support in the $41-$42 price area. If the shares can firm up, we see overhead resistance around the $46-$48 price levels.

Merck & Co., Inc. ( MRK ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: MRK



Latest News Video

Obama Talks Limiting Drone Strikes, Closing Gitmo in Speech
Obama Talks Limiting Drone Strikes,...
House Moves to Change Student Loans
House Moves to Change Student Loans
Vendor Brings Snow Cones Into Bathroom Stall at Astros Game
Vendor Brings Snow Cones Into Bathr...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.21 0.10  0.75%
HPQ $ 24.86 3.63  17.10%
SIRI $ 3.545 0.01  0.28%
MU $ 11.39 0.47  4.30%
MSFT $ 34.15 0.46  1.33%
F $ 14.81 0.16  1.07%
QQQ $ 73.45 0.17  0.23%
GE $ 23.66 0.20  0.84%